Phase 1 Study of TAS0612
Research payments
$1,424,616
Through program year 2025, $1,424,616 in research payments was reported against Phase 1 Study of TAS0612, across 125 payments, paid by Taiho Oncology, Inc..
- Paid by
- Taiho Oncology, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $302,392 | 44 |
| 2024 | Research | $213,720 | 20 |
| 2023 | Research | $184,800 | 39 |
| 2022 | Research | $472,805 | 21 |
| 2021 | Research | $250,899 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Erika Hamilton Nashville, TN Named on 102 payments
- Funda Meric-Bernstam Houston, TX Named on 15 payments
- Thomas Enzler Ann Arbor, MI Named on 3 payments
- Bert Oneil Indianapolis, IN Named on 2 payments
- Lee Rosen Santa Monica, CA Named on 2 payments
- Heather Yeckes Rodin Port St. Lucie, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.